Table 4.
Response | PDN (n=36), n (%) | HD-DXM (n=36), n (%) | OR (95% CI) | P† |
---|---|---|---|---|
Initial response* | 11 (30.6) | 25 (69.4) | 5.68 (2.05–15.76) | 0.001 |
Complete response** | 3 (8.3) | 8 (22.2) | 3.05 (0.74–12.62) | 0.124 |
Sustained response*** | 24 (66.7) | 32 (88.9) | 4.17 (1.19–14.60) | 0.025 |
*Initial response=Platelet count over 30×109/l after 1 month from treatment; **Complete response=Platelet count over 100×109/l after 1 month from treatment; ***Sustained response=Platelet count over 30×109/l for at least 6 months from treatment; †Significance level calculated from logistic regression with adjusted of other parameters such as age, gender, and bleeding score. PDN=Prednisone; HD-DXM=High-dose dexamethasone; OR=Odds ratio; CI=Confidence interval